TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis.
Veronique de Jager et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.